Abstract
Decentralized clinical trials (DCTs) employ innovative approaches to conduct research outside traditional clinical sites. Low- and middle-income countries like Nigeria, with limited infrastructure, insufficient manpower, and inadequate financial support for trials, can benefit from DCTs. By leveraging non-traditional infrastructure, such as community pharmacies, DCT approaches could overcome some infrastructural and recruitment challenges common in clinical trials in African countries. The extensive community pharmacy network in Nigeria could be strategically positioned as partners in DCT efforts.